Avalo Therapeutics, Inc. · NASDAQ:AVTX
Riley Jennifer had 588 Avalo Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Jun 10, 2026 · Filed Jun 12, 2026
On Jun 10, 2026, Riley Jennifer (Chief Strategy Officer) had 588 Avalo Therapeutics, Inc. shares withheld for tax at US$13.10 for US$7,703, leaving 39,696 shares. Filed Jun 12, 2026 (Form 4).
- Withheld for tax
- 588 shares
- Price
- US$13.10
- Value
- US$7,703
- Holding after
- 39,696 shares
- Trading plan
- No
- Role
- Chief Strategy Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | Shares withheld for tax | 588 | US$13.10 | 39,696 | Direct |
Source
Related
- Avalo Therapeutics, Inc.
- Riley Jennifer
- Avalo Therapeutics, Inc. shareholders
- Form 4 · Riley Jennifer · Aug 12, 2026
- Form 4 · Riley Jennifer · May 26, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026